Apogee Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $10.0M | $152.1M | $151.9M |
| FY2023 | $21.5M | $401.4M | $118.3M |
| FY2024 | $37.2M | $754.0M | $141.8M |
| FY2025 | $33.3M | $937.1M | $131.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $10.0M | $152.1M | $151.9M |
| FY2023 | $21.5M | $401.4M | $118.3M |
| FY2024 | $37.2M | $754.0M | $141.8M |
| FY2025 | $33.3M | $937.1M | $131.5M |